Since the merger last year, I’d like to know what our partner, Ilera Therapeutics has brought to the table to get us to this point in Zilera’s existence?
The insomnia clinical trial was already in play at the time of the merger, so today’s positive results were a given, without Ilera as a joint partner.
I and many others were hoping that Ilera had a decent balance sheet to stave off an expected CR that we all knew was going to come for Zelda at the time.
But we now know that Ilera didn’t bring any cash to the table, because of the need for the recent CR.
So could anyone enlighten me as to Ilera’s value add to zeliras’ progress to this point that would not otherwise have occurred, without the merger?
- Forums
- ASX - By Stock
- Ann: Zelira Meets Primary Endpoints for Insomnia Trial
Since the merger last year, I’d like to know what our partner,...
-
- There are more pages in this discussion • 174 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ZLD (ASX) to my watchlist
(20min delay)
|
|||||
Last
72.0¢ |
Change
0.020(2.86%) |
Mkt cap ! $8.169M |
Open | High | Low | Value | Volume |
71.0¢ | 75.0¢ | 71.0¢ | $2.142K | 2.893K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8 | 73.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
80.0¢ | 466 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8 | 0.735 |
1 | 394 | 0.710 |
2 | 14488 | 0.700 |
2 | 2145 | 0.690 |
2 | 1668 | 0.680 |
Price($) | Vol. | No. |
---|---|---|
0.800 | 466 | 1 |
0.940 | 40000 | 1 |
0.950 | 1429 | 1 |
0.980 | 1021 | 2 |
1.010 | 1000 | 1 |
Last trade - 13.49pm 04/10/2024 (20 minute delay) ? |
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
ZLD (ASX) Chart |